Accreditation is essential for ensuring patient safety and maintaining high standards of care, but it shouldn’t become a barrier to access. As cell and gene therapies continue to advance, expanding accreditation criteria responsibly can bring more qualified centres online, helping to meet growing patient demand and reduce treatment delays.

A balanced approach allows healthcare systems to maintain rigorous oversight while fostering flexibility and innovation in how therapies are delivered. Streamlined yet robust frameworks can help align payers, regulators, and treatment centres, ensuring that quality and access progress together. By evolving accreditation to match the pace of innovation, we can unlock capacity across the network and ensure that life-changing therapies reach patients faster, safely, and sustainably.

Link to article